MedTrace Logo

Effectiveness of Biodentine v/s Calcium Hydroxide as Indirect Pulp Capping Materials

NCT07147036 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2025-09-15

No results posted yet for this study

Summary

This study compares the clinical and radiographic effectiveness of Biodentine and Calcium Hydroxide as indirect pulp capping materials in mature permanent teeth with reversible pulpitis. A total of 76 patients were randomly assigned to two groups. Outcomes were assessed over 12 weeks based on pain, periapical radiolucency, and PDL widening. The goal was to determine which material better preserves pulp vitality

Conditions

  • Reversible Pulpitis

Interventions

PROCEDURE

Biodentine - Indirect Pulp Capping

Caries removal under rubber dam isolation using round bur (#BR-45) and water spray Tooth disinfection with 0.2% chlorhexidine Mixing of Biodentine (Septodont, France) in an amalgamator (30 seconds at 4000 rpm) Placement of Biodentine into the prepared cavity using an amalgam carrier and condensation After 1 week: Placement of self-cure GIC (Fuji, Japan) as a base Final restoration with light-cure composite resin Follow-up at 2, 6, and 12 weeks

PROCEDURE

Calcium Hydroxide - Indirect Pulp Capping

Caries removal under rubber dam isolation using round bur (#BR-45) and water spray Tooth disinfection with 0.2% chlorhexidine Cavity dried with cotton pellet Placement of a 0.5 mm layer of Calcium Hydroxide (Dycal) After 2-3 minutes (setting time): Placement of self-cure GIC (Fuji, Japan) After 1 week: Final restoration with light-cure composite resin Follow-up at 2, 6, and 12 weeks

Sponsors & Collaborators

  • HITEC-Institute of Medical Sciences

    collaborator OTHER

  • Zahoor khan

    lead OTHER

Principal Investigators

  • Dr Zahoor Dr Zahoor khan, BDS, FCPS · Dental college HITEC-IMS Taxila

  • Dr Zahoor khan · Dental college HITEC-IMS Taxila

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-05
Primary Completion
2024-02-05
Completion
2024-02-05

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07147036 on ClinicalTrials.gov